Recombinant Rhesus monkey SOCS3 Protein, His-tagged
Cat.No. : | SOCS3-4402R |
Product Overview : | Recombinant Rhesus monkey SOCS3 full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
- Download
Source : | Mammalian Cells |
Species : | Rhesus monkey |
Tag : | His |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC. |
Storage Buffer : | PBS buffer |
Gene Name : | SOCS3 suppressor of cytokine signaling 3 [ Macaca mulatta (Rhesus monkey) ] |
Official Symbol : | SOCS3 |
Synonyms : | SOCS3; suppressor of cytokine signaling 3; |
Gene ID : | 715680 |
mRNA Refseq : | NM_001194326 |
Protein Refseq : | NP_001181255 |
MIM : | |
UniProt ID : | F6UUY8 |
Products Types
◆ Recombinant Protein | ||
SOCS3-5324R | Recombinant Rat SOCS3 Protein, His (Fc)-Avi-tagged | +Inquiry |
SOCS3-1526R | Recombinant Rat SOCS3 Protein (1-225 aa), His-tagged | +Inquiry |
SOCS3-3895H | Recombinant Human SOCS3 protein(Met1-Leu225), His&Trx-tagged | +Inquiry |
SOCS3-2068H | Recombinant Human SOCS3 Protein, His (Fc)-Avi-tagged | +Inquiry |
SOCS3-4218R | Recombinant Rhesus Macaque SOCS3 Protein, His (Fc)-Avi-tagged | +Inquiry |
◆ Lysates | ||
SOCS3-1580HCL | Recombinant Human SOCS3 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewSOCS3 is very stable in Western blot, and its performance will not be affected even if it is stored for a long time.
SOCS3 has long-lasting effects and sustained release performance.
This synthesis cost and application cost are moderate, and it is cost-effective for production.
Q&As (6)
Ask a questionTherapeutic strategies for SOCS3 can include regulating its expression level, blocking its interaction with other proteins, or regulating its associated signal transduction pathways. These approaches may have potential applications in the treatment of autoimmune diseases, inflammatory diseases, and certain cancers.
The structure of SOCS3 determines its ability and stability to bind to other proteins. The study of its structure can help us understand its function and mechanism of action.
In inflammatory diseases, SOCS3 may reduce the inflammatory response by inhibiting the production and release of pro-inflammatory cytokines and promoting the expression of anti-inflammatory factors. It could be a potential target for the treatment of inflammatory diseases.
This protein can interact with a variety of other proteins, including JAK kinase, STAT transcription factors, etc. These interactions enable it to regulate processes such as cell growth, differentiation, and apoptosis.
Drug development for SOCS3 requires consideration of its specificity, safety, pharmacokinetic properties, and potential side effects. In addition, issues such as the dosage form, route of administration and design of clinical trials need to be considered.
SOCS3 is primarily involved in immunosuppressive and anti-inflammatory responses in the immune system. It can inhibit the production and release of pro-inflammatory cytokines and promote the expression of anti-inflammatory factors, thereby reducing the inflammatory response.
Ask a Question for All SOCS3 Products
Required fields are marked with *
My Review for All SOCS3 Products
Required fields are marked with *
Inquiry Basket